Green tea extract shows promise in leukaemia trials
Wednesday, May 27, 2009 - 05:35
in Health & Medicine
Mayo Clinic researchers are reporting positive results in early leukaemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea. The trial determined that patients with chronic lymphocytic leukaemia (CLL) can tolerate the chemical fairly well when high doses are administered in capsule form and that lymphocyte count was reduced in one-third of participants. The findings appear today online in the Journal of Clinical Oncology...
Read the whole article on Science Centric
More from Science Centric
Related
- Green tea extract shows promise in leukemia trialsTue, 26 May 2009, 16:50:38 EDT
- Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adultsFri, 11 Sep 2009, 13:39:48 EDT
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- National call for cancer clinical trial system to be more responsive to community needsTue, 11 Nov 2008, 12:53:49 EST
- Results from TH-302 clinical trials presented at international lung cancer meetingThu, 6 Aug 2009, 17:30:56 EDT